Search

everythinglearnresearchcommunity

for

Search:↓

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Alopecia areata involves both innate and adaptive immunity, with specific genes linked to the disease.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

Polycystic ovary syndrome costs the U.S. over $4 billion a year, mainly from treating related health issues.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

The research shows that a gene called Wnt3 affects hair growth and structure, causing short hair and balding when overactive.

Apoptosis is essential for human skin development and forming a functional epidermis.

The document concludes that recent research has improved understanding of skin diseases and the balance between cell growth and differentiation in the epidermis.

Blocking the enzyme 5α-reductase can shrink the prostate and help treat enlarged prostate issues.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

The human sebocyte culture model has improved understanding of oily skin and acne, and how they can be treated.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.

Sebocytes play a key role in controlling androgen levels in human skin.

Men are more likely to have severe COVID-19 cases and fatalities than women due to factors like lifestyle, aging, and biological differences.

Blocking the enzyme that turns testosterone into DHT can safely and effectively treat enlarged prostate.

Women with PCOS face higher risks of diabetes and heart disease, and these risks increase with obesity.

A man with vitiligo and alopecia saw quick skin and hair improvement with ruxolitinib, but skin color gains were lost after stopping treatment.

AXR3 and SHY2 genes control the growth and timing of root hair development in plants.

Women with PCOS have a higher risk of diabetes and heart problems, especially when they get older.

Minoxidil boosts hair growth by increasing cell production and survival.

Low oxygen conditions increase the hair-growing effects of substances from fat-derived stem cells by boosting growth factor release.

The conclusion is that PCOS is caused by ovarian sensitivity to hormones and disrupted hormone control, possibly due to ovarian factors, and more research is needed.

Obesity is linked to various skin problems and may increase the risk of skin cancer.

Foxp3 is crucial for regulatory T cell function, and targeting these cells may help treat immune disorders.

Polycystic Ovary Syndrome likely starts in childhood and may be genetic and influenced by early hormone exposure.

Key enzymes control androgen levels, affecting hormone activity and potential treatments.

Green tea component EGCG could potentially promote human hair growth.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.